Glypican 3 Expression in Urothelial Carcinoma: A Histopathological and Immunohistochemical Study
Solafa Amin Abd Al Aziz, Samia Mohamad Gabal, Wael Moustafa Mohamad and 1 more
Journal of Clinical and Diagnostic Research · 2019
doi:10.7860/jcdr/2019/39883.12593 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: Glypican 3 (GPC3) is an oncofetal protein, playing a role in cell regulation during fetal development, via Wingless/Integration (Wnt) signaling pathway. GPC3 immunohistochemical expression was detected in several tumours, most obvious in hepatocellular carcinoma. The GPC3 antibody is under clinical trials for the therapeutic approach of hepatocellular carcinoma. Aim: Correlation of glypican 3 expression in urothelial carcinoma with clinicopathological features, to detect its possible role in stimulating Wnt signaling which is supposed to be responsible for urothelial carcinogenesis, where GPC3 can be used as a future therapeutic target. Materials and Methods: This retrospective study included a total of 125 archived, formalin fixed, paraffin embedded tissue blocks of 125 cases of UC, including 90 cases of radical cystectomies with high-grade UC and 35 cases of Transurethral Resection of Bladder Tumour (TURT) with low-grade UC. The samples were immunohistochemically analysed for GPC3 expression. Results: A statistically significant correlation was detected between GPC3 expression and tumour (T) stage (p-value=0.047). Conclusion: GPC3 has a partial role in urothelial carcinogenesis. Further studies are needed to investigate the possible role of GPC3 in differentiation between low and high-grade UC. Also, GPC3 may differentiate between neoplastic and non-neoplastic urothelial tissue.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.